Clinical Trial

FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

Name: FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence — clinical trial record (NCT07647198)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FATIMA

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-10.

Trial Details

NCT Number	NCT07647198
Lead Sponsor	Sheikh Shakhbout Medical City
Conditions	Uterine Fibroids (Leiomyoma)
Enrollment	240 participants
Start Date	2026-08-22
Primary Completion	2029-08-22 (estimated)
Study Completion	2029-12-22 (estimated)
Updated on ClinicalTrials.gov	2026-06-16